Journal of Clinical Endocrinology & Metabolism, Vol 81, 1623-1627, Copyright © 1996 by Endocrine Society

ARTICLES

Localization of insulinomas by selective intraarterial calcium injection

D O'Shea, AW Rohrer-Theurs, JA Lynn, JE Jackson and SR Bloom
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital London, United Kingdom.

This study examines the role of selective intraarterial calcium injection and hepatic venous sampling in the localization of insulinomas. Seven patients were studied. In all cases, ultrasound and computerized tomography scans were either negative or equivocal. Calcium gluconate was injected directly into the arteries supplying the pancreas after standard selective angiography. Insulin levels were measured in samples taken from the right hepatic vein before and 30, 60, 90, 120, and 180 s after each injection. Two doses were used, 0.025 milliequivalents Ca/kg (1 mg/kg) for the first two subjects and 0.00625 milliequivalents Ca/kg (0.25 mg/kg) for the remaining five subjects. Serum insulin levels rose at least 2-fold, the proposed diagnostic rise, from basal in six subjects; one test was negative. Of the six positive studies, a diagnostic rise was seen only in one artery in five cases. One patient did not undergo surgery. In the remaining five patients, surgery confirmed the position and histology of the tumor. The one patient with a diagnostic rise in more than one artery, however, had residual disease after surgery. The seventh subject referred specifically for localization had a negative calcium stimulation study and a subsequent diagnosis of intermittent sulfonylurea abuse was made after a positive screen. The present study shows that preoperatively, selective intraarterial calcium injection with hepatic venous sampling is a powerful technique for the localization of insulinomas. Smaller doses of calcium than previously reported can be used and may reduce the risk of hypoglycemia during the procedure.

This article has been cited by other articles:

				G. A. Kaltsas, G. M. Besser, and A. B. Grossman The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors Endocr. Rev., June 1, 2004; 25(3): 458 - 511. [Abstract] [Full Text] [PDF]

				A. Park, M. Edwards, M. Donaldson, M. Ghatei, and K. Meeran Lesson of the week: Interfering antibodies affecting immunoassays in woman with pet rabbits BMJ, March 8, 2003; 326(7388): 541 - 542. [Full Text] [PDF]

				M. Nakagawa, F. Sasakuma, Y. Kishi, and O. Ishikawa A Successful Monitoring for Intraoperative Calcium Stimulation Test in Complete Resection of Pancreatic Insulinoma Anesth. Analg., July 1, 2001; 93(1): 239 - 240. [Abstract] [Full Text] [PDF]

				R. M. Witteles, F. H. Straus II, S. L. Sugg, M. R. Koka, E. A. Costa, and E. L. Kaplan Adult-Onset Nesidioblastosis Causing Hypoglycemia: An Important Clinical Entity and Continuing Treatment Dilemma Arch Surg, June 1, 2001; 136(6): 656 - 663. [Abstract] [Full Text] [PDF]

				J. Furrer, A. Hättenschwiler, P. Komminoth, T. Pfammatter, and P. Wiesli Carcinoid Syndrome, Acromegaly, and Hypoglycemia Due to an Insulin-Secreting Neuroendocrine Tumor of the Liver J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2227 - 2230. [Abstract] [Full Text]

				F. J. Service, N. Natt, G. B. Thompson, C. S. Grant, J. A. van Heerden, J. C. Andrews, E. Lorenz, A. Terzic, and R. V. Lloyd Noninsulinoma Pancreatogenous Hypoglycemia: A Novel Syndrome of Hyperinsulinemic Hypoglycemia in Adults Independent of Mutations in Kir6.2 and SUR1 Genes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1582 - 1589. [Abstract] [Full Text]

				S. G. Straub, B. Kornreich, R. E. Oswald, E. F. Nemeth, and G. W. G. Sharp The Calcimimetic R-467 Potentiates Insulin Secretion in Pancreatic beta Cells by Activation of a Nonspecific Cation Channel J. Biol. Chem., June 16, 2000; 275(25): 18777 - 18784. [Abstract] [Full Text] [PDF]